257 related articles for article (PubMed ID: 17370394)
1. [Anti Pseudomonas aeruginosa antibiotic therapy in cystic fibrosis (exclusion of macrolides)].
Sermet-Gaudelus I; Ferroni A; Vrielinck S; Lebourgeois M; Chedevergne F; Lenoir G
Arch Pediatr; 2006 Oct; 13 Suppl 1():S30-43. PubMed ID: 17370394
[TBL] [Abstract][Full Text] [Related]
2. [Antibiotic therapy in cystic fibrosis. II Antibiotic strategy].
Sermet-Gaudelus I; Ferroni A; Gaillard JL; Silly C; Chretiennot C; Lenoir G; Berche P
Arch Pediatr; 2000 Jun; 7(6):645-56. PubMed ID: 10911533
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
[TBL] [Abstract][Full Text] [Related]
4. Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
Murray TS; Egan M; Kazmierczak BI
Curr Opin Pediatr; 2007 Feb; 19(1):83-8. PubMed ID: 17224667
[TBL] [Abstract][Full Text] [Related]
5. Eradication of early Pseudomonas aeruginosa infection.
Høiby N; Frederiksen B; Pressler T
J Cyst Fibros; 2005 Aug; 4 Suppl 2():49-54. PubMed ID: 16023416
[TBL] [Abstract][Full Text] [Related]
6. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
7. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Ratjen F
Curr Opin Pulm Med; 2006 Nov; 12(6):428-32. PubMed ID: 17053493
[TBL] [Abstract][Full Text] [Related]
8. [Macrolides, Pseudomonas aeruginosa and cystic fibrosis].
Guillot M; Amiour M; El Hachem C; Harchaoui S; Ribault V; Paris C
Arch Pediatr; 2006 Oct; 13 Suppl 1():S48-50. PubMed ID: 17370396
[TBL] [Abstract][Full Text] [Related]
9. [Detection and management of early Pseudomonas aeruginosa infection in patients with cystic fibrosis].
Kernen Y; Sauty A; Roulet M
Rev Med Suisse; 2005 Mar; 1(9):637-8, 640. PubMed ID: 15813341
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
Zabner R; Quinn JP
Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544
[TBL] [Abstract][Full Text] [Related]
11. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
12. The approach to Pseudomonas aeruginosa in cystic fibrosis.
Bendiak GN; Ratjen F
Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
[TBL] [Abstract][Full Text] [Related]
13. Approaches to the treatment of initial Pseudomonas aeruginosa infection in children who have cystic fibrosis.
Lahiri T
Clin Chest Med; 2007 Jun; 28(2):307-18. PubMed ID: 17467550
[TBL] [Abstract][Full Text] [Related]
14. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
Nichols L; Maki DG
Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
[TBL] [Abstract][Full Text] [Related]
15. [Pseudomonas aeruginosa and cystic fibrosis: non-antibiotic strategy].
Foucaud P; de Truchis A; Tassin E; Allouch P; Pangon B
Arch Pediatr; 2006 Oct; 13 Suppl 1():S44-7. PubMed ID: 17370395
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa and the airways disease of cystic fibrosis.
Hata JS; Fick RB
Clin Chest Med; 1988 Dec; 9(4):679-89. PubMed ID: 3148384
[TBL] [Abstract][Full Text] [Related]
17. Phenotypes selected during chronic lung infection in cystic fibrosis patients: implications for the treatment of Pseudomonas aeruginosa biofilm infections.
Ciofu O; Mandsberg LF; Wang H; Høiby N
FEMS Immunol Med Microbiol; 2012 Jul; 65(2):215-25. PubMed ID: 22540844
[TBL] [Abstract][Full Text] [Related]
18. Update on treatment of pulmonary exacerbations in cystic fibrosis.
Smyth A
Curr Opin Pulm Med; 2006 Nov; 12(6):440-4. PubMed ID: 17053495
[TBL] [Abstract][Full Text] [Related]
19. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
Etherington C; Hall M; Conway S; Peckham D; Denton M
J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
